Translational research approach to biological and modifiable risk factors of psychosis and affective disorders

References

• Alvarenga ME, Caniato RN, Mauritz A, Braun A, Aljeesh Y, Baune BT. 2009. Health service utilization in patients with major depression and co-morbid pain. Psychiatry Clin Neurosci 63:101–106.
   PubMedGoogle Scholar
• Arolt V, Fein A, Driessen M, Dorlochter L, Maintz C. 1998. Depression and social functioning in general hospital in-patients. J Psychosom Res 45:117–126.
   PubMedGoogle Scholar
• Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. 2002. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Br Med J 325:1212–1213.
   PubMed Web of Science ®Google Scholar
• Aslund C, Leppert J, Comasco E, Nordquist N, Oreland L, Nilsson KW. 2009. Impact of the interaction between the 5HTTLPR polymorphism and maltreatment on adolescent depression. A population-based study. Behav Genet 39:524–531.
   PubMed Web of Science ®Google Scholar
• Baune BT, Aljeesh Y. 2006. The association of psychological stress and health related quality of life among patients with stroke and hypertension in Gaza Strip. Ann Gen Psychiatry 5:6.
   PubMedGoogle Scholar
• Baune BT, Adrian I, Arolt V, Berger K. 2006. Associations between major depression, bipolar disorders, dysthymia and cardiovascular diseases in the general adult population. Psychother Psychosom 75:319–326.
   PubMed Web of Science ®Google Scholar
• Baune BT, Adrian I, Jacobi F. 2007. Medical disorders affect health outcome and general functioning depending on comorbid major depression in the general population. J Psychosom Res 62:109–118.
   PubMed Web of Science ®Google Scholar
• Baune BT, Caniato RN, Arolt V, Berger K. 2009a. The effects of dysthymic disorder on health-related quality of life and disability days in persons with comorbid medical conditions in the general population. Psychother Psychosom 78:161–166.
   PubMedGoogle Scholar
• Baune BT, McAfoose J, Leach G, Quirk F, Mitchell D. 2009b. Impact of psychiatric and medical comorbidity on cognitive function in depression. Psychiatry Clin Neurosci 63:392–400.
   PubMed Web of Science ®Google Scholar
• Beardslee WR, Versage EM, Gladstone TR. 1998. Children of affectively ill parents: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 37:1134–1141.
   PubMed Web of Science ®Google Scholar
• Bebbington PE, Bhugra D, Brugha T, Singleton N, Farrell M, Jenkins R, . 2004. Psychosis, victimisation and childhood disadvantage: evidence from the second British National Survey of Psychiatric Morbidity. Br J Psychiatry 185:220–6.
   PubMed Web of Science ®Google Scholar
• Beblo T, Sinnamon G, Baune BT. 2011. Specifying the neuropsychology of affective disorders: clinical, demographic and neurobiological factors. Neuropsychol Rev Jun 10. [Epub ahead of print].
   PubMedGoogle Scholar
• Berto P, D'Ilario D, Ruffo P, Di Virgilio R, Rizzo F. 2000. Depression: cost-of-illness studies in the international literature, a review. J Ment Health Policy Econ 3:3–10.
   PubMedGoogle Scholar
• Booth BM, Zhang M, Rost KM, Clardy JA, Smith LG, Smith GR. 1997. Measuring outcomes and costs for major depression. Psychopharmacol Bull 33:653–658.
   PubMedGoogle Scholar
• Brown AS. 2011. The environment and susceptibility to schizophrenia. Prog Neurobiol 93:23–58.
   PubMed Web of Science ®Google Scholar
• Brown AS, Derkits EJ. 2010. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 167:261–280.
   PubMed Web of Science ®Google Scholar
• Brown S, Inskip H, Barraclough B. 2000. Causes of the excess mortality of schizophrenia. Br J Psychiatry 177:212–217.
   PubMed Web of Science ®Google Scholar
• Cantor-Graae E, Selten JP. 2005. Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry 162:12–24.
   PubMed Web of Science ®Google Scholar
• Carlson C, Hornbuckle K, DeLisle F, Kryzhanovskaya L, Breier A, Cavazzoni P. 2006. Diabetes mellitus and antipsychotic treatment in the United Kingdom. Eur Neuropsychopharmacol 16:366–375.
   PubMed Web of Science ®Google Scholar
• Caspi A, Moffitt TE. 2006. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 7:583–590.
   PubMed Web of Science ®Google Scholar
• Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, . 2003. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386–389.
   PubMed Web of Science ®Google Scholar
• Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE. 2010. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 167:509–527.
   PubMed Web of Science ®Google Scholar
• Colman I, Ataullahjan A. 2010. Life course perspectives on the epidemiology of depression. Can J Psychiatry 55:622–632.
   PubMed Web of Science ®Google Scholar
• Colman I, Ploubidis GB, Wadsworth ME, Jones PB, Croudace TJ. 2007. A longitudinal typology of symptoms of depression and anxiety over the life course. Biol Psychiatry 62:1265–1271.
   PubMed Web of Science ®Google Scholar
• Colman I, Croudace TJ, Wadsworth ME, Kuh D, Jones PB. 2008. Psychiatric outcomes 10 years after treatment with antidepressants or anxiolytics. Br J Psychiatry 193:327–331.
   PubMedGoogle Scholar
• Degreef G, Bogerts B, Falkai P, Greve B, Lantos G, Ashtari M, Lieberman J. 1992. Increased prevalence of the cavum septum pellucidum in magnetic resonance scans and post-mortem brains of schizophrenic patients. Psychiatry Res 45:1–13.
   PubMed Web of Science ®Google Scholar
• DeLisi LE, Hoff AL, Kushner M, Degreef G. 1993. Increased prevalence of cavum septum pellucidum in schizophrenia. Psychiatry Res 50:193–199.
   PubMed Web of Science ®Google Scholar
• Dixon L, Weiden P, Delahanty J, Goldberg R, Postrado L, Lucksted A, Lehman A. 2000. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 26:903–912.
   PubMed Web of Science ®Google Scholar
• Dohrenwend BP, Levav I, Shrout PE, Schwartz S, Naveh G, Link BG, . 1992. Socioeconomic status and psychiatric disorders: the causation-selection issue. Science 255:946–952.
   PubMed Web of Science ®Google Scholar
• Eaton WW. 1985. Epidemiology of schizophrenia. Epidemiol Rev 7:105–126.
   PubMed Web of Science ®Google Scholar
• Fang J, Cheng Q. 2009. Etiological mechanisms of post-stroke depression: a review. Neurol Res 31:904–909.
   PubMed Web of Science ®Google Scholar
• Feinstein A. 2004. The neuropsychiatry of multiple sclerosis. Can J Psychiatry 49:157–163.
   PubMed Web of Science ®Google Scholar
• Felker B, Katon W, Hedrick SC, Rasmussen J, McKnight K, McDonnell MB, Fihn SD. 2001. The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry 23:56–61.
   PubMed Web of Science ®Google Scholar
• Frasure-Smith N, Lesperance F. 2010. Depression and cardiac risk: present status and future directions. Heart 96:173–176.
   PubMed Web of Science ®Google Scholar
• Gale CR, Deary IJ, Boyle SH, Barefoot J, Mortensen LH, Batty GD. 2008. Cognitive ability in early adulthood and risk of 5 specific psychiatric disorders in middle age: the Vietnam experience study. Arch Gen Psychiatry 65:1410–1418.
   PubMed Web of Science ®Google Scholar
• Gendelman N, Snell-Bergeon JK, McFann K, Kinney G, Paul Wadwa R, Bishop F, . 2009. Prevalence and correlates of depression in individuals with and without type 1 diabetes. Diabetes Care 32:575–579.
   PubMed Web of Science ®Google Scholar
• Gilman SE, Kawachi I, Fitzmaurice GM, Buka SL. 2002. Socioeconomic status in childhood and the lifetime risk of major depression. Int J Epidemiol 31:359–367.
   PubMed Web of Science ®Google Scholar
• Goodyer IM, Bacon A, Ban M, Croudace T, Herbert J. 2009. Serotonin transporter genotype, morning cortisol and subsequent depression in adolescents. Br J Psychiatry 195:39–45.
   PubMed Web of Science ®Google Scholar
• Gottesman II, Shields J. 1976. A critical review of recent adoption, twin, and family studies of schizophrenia: behavioral genetics perspectives. Schizophr Bull 2:360–401.
   PubMed Web of Science ®Google Scholar
• Grabe HJ, Lange M, Wolff B, Volzke H, Lucht M, Freyberger HJ, . 2005. Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry 10:220–224.
   PubMed Web of Science ®Google Scholar
• Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, Corey-Lisle PK. 2003. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 64:1465–1475.
   PubMed Web of Science ®Google Scholar
• Horwood LJ, Fergusson DM. 1986. Neuroticism, depression and life events: a structural equation model. Soc Psychiatry 21:63–71.
   PubMedGoogle Scholar
• Hunkeler EM, Spector WD, Fireman B, Rice DP, Weisner C. 2003. Psychiatric symptoms, impaired function, and medical care costs in an HMO setting. Gen Hosp Psychiatry 25:178–184.
   PubMedGoogle Scholar
• Janssen I, Krabbendam L, Bak M, Hanssen M, Vollebergh W, de Graaf R, van Os J. 2004. Childhood abuse as a risk factor for psychotic experiences. Acta Psychiatr Scand 109:38–45.
   PubMed Web of Science ®Google Scholar
• Jones DR, Macias C, Barreira PJ, Fisher WH, Hargreaves WA, Harding CM. 2004. Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness. Psychiatr Serv 55:1250–1257.
   PubMed Web of Science ®Google Scholar
• Katon W, Russo J, Lin E, Heckbert S, Ciechanowski P, Ludman E, Korff M. 2009. Depression and diabetes: factors associated with major depression at five-year follow-up. Psychosomatics 50:570.
   PubMedGoogle Scholar
• Katon WJ. 2003. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 54:216–226.
   PubMed Web of Science ®Google Scholar
• Katon WJ. 2011. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci 13:7–23.
   PubMedGoogle Scholar
• Kendler KS, Gardner CO, Prescott CA. 2002. Toward a comprehensive developmental model for major depression in women. Am J Psychiatry 159:1133–1145.
   PubMed Web of Science ®Google Scholar
• Kendler KS, Gardner CO, Prescott CA. 2006. Toward a comprehensive developmental model for major depression in men. Am J Psychiatry 163:115–124.
   PubMed Web of Science ®Google Scholar
• Kirkbride JB, Fearon P, Morgan C, Dazzan P, Morgan K, Tarrant J, . 2006. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry 63:250–258.
   PubMed Web of Science ®Google Scholar
• Kornegay CJ, Vasilakis-Scaramozza C, Jick H. 2002. Incident diabetes associated with antipsychotic use in the United Kingdom general practice research database. J Clin Psychiatry 63:758–762.
   PubMed Web of Science ®Google Scholar
• Krieger N. 1994. Epidemiology and the web of causation: has anyone seen the spider? Soc Sci Med 39:887–903.
   PubMed Web of Science ®Google Scholar
• Kwon JS, Shenton ME, Hirayasu Y, Salisbury DF, Fischer IA, Dickey CC, . 1998. MRI study of cavum septi pellucidi in schizophrenia, affective disorder, and schizotypal personality disorder. Am J Psychiatry 155:509–515.
   PubMed Web of Science ®Google Scholar
• Lamberti JS, Olson D, Crilly JF, Olivares T, Williams GC, Tu X, . 2006. Prevalence of the metabolic syndrome among patients receiving clozapine. Am J Psychiatry 163:1273–1276.
   PubMed Web of Science ®Google Scholar
• Lawrie SM, Abukmeil SS. 1998. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry 172:110–120.
   PubMed Web of Science ®Google Scholar
• Leonhard B. 2007. Inflammation, depression and dementia: are they connected? Neurochem Res 32:1749–1756.
   PubMedGoogle Scholar
• Leucht S, Burkard T, Henderson J, Maj M, Sartorius N. 2007. Physical illness and schizophrenia. A review of the evidence. Cambridge: Cambridge University Press.
   Google Scholar
• Levinson DF. 2006. The genetics of depression: a review. Biol Psychiatry 60:84–92.
   PubMed Web of Science ®Google Scholar
• Licinio J. 2010. The First International Conference on Translational Medicine. Mol Psychiatry 15:878–879.
   PubMedGoogle Scholar
• Licinio J. 2011. Translational psychiatry: leading the transition from the cesspool of devastation to a place where the grass is really greener. Transl Psychiatry 1 el; doi:10.1038/tp.2011.3; published online 4 April 2011.
   Google Scholar
• Mancuso CA, Peterson MG, Charlson ME. 2000. Effects of depressive symptoms on health-related quality of life in asthma patients. J Gen Intern Med 15:301–310.
   PubMed Web of Science ®Google Scholar
• McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. 2004. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med 2:13.
   PubMed Web of Science ®Google Scholar
• McMichael AJ. 1999. Prisoners of the proximate: loosening the constraints on epidemiology in an age of change. Am J Epidemiol 149:887–897.
   PubMed Web of Science ®Google Scholar
• Meyer JM, Nasrallah HA, McEvoy JP, Goff DC, Davis SM, Chakos M, . 2005. The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. Schizophr Res 80:9–18.
   PubMed Web of Science ®Google Scholar
• Meyer-Lindenberg A. 2010. From maps to mechanisms through neuroimaging of schizophrenia. Nature 468:194–202.
   PubMed Web of Science ®Google Scholar
• Musselman DL, Betan E, Larsen H, Phillips LS. 2003. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 54:317–329.
   PubMed Web of Science ®Google Scholar
• Nelson MD, Saykin AJ, Flashman LA, Riordan HJ. 1998. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 55:433–440.
   PubMed Web of Science ®Google Scholar
• Osborn DP, Nazareth I, King MB. 2006. Risk for coronary heart disease in people with severe mental illness: cross-sectional comparative study in primary care. Br J Psychiatry 188:271–277.
   PubMed Web of Science ®Google Scholar
• Oud MJ, Meyboom-de Jong B. 2009. Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care. BMC Fam Pract 10:32.
   PubMed Web of Science ®Google Scholar
• Paizanis E, Hamon M, Lanfumey L. 2007. Hippocampal neurogenesis, depressive disorders, and antidepressant therapy. Neural Plast 2007:73754.
   PubMedGoogle Scholar
• Pohle K, Domschke K, Roehrs T, Arolt V, Baune BT. 2009. Medical comorbidity affects antidepressant treatment response in patients with melancholic depression. Psychother Psychosom 78:359–363.
   PubMed Web of Science ®Google Scholar
• Remington JS, Klein JO. 2006. Infectious diseases of the fetus and newborn infant. Philadelphia, PA: Elsevier Saunders.
   Google Scholar
• Risch N, Herrell R, Lehner T, Liang KY, Eaves L, Hoh J, . 2009. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. J Am Med Assoc 301:2462–2471.
   PubMed Web of Science ®Google Scholar
• Sacchetti E, Turrina C, Parrinello G, Brignoli O, Stefanini G, Mazzaglia G. 2005. Incidence of diabetes in a general practice population: a database cohort study on the relationship with haloperidol, olanzapine, risperidone or quetiapine exposure. Int Clin Psychopharmacol 20:33–37.
   PubMedGoogle Scholar
• Samele C, Patel M, Boydell J, Leese M, Wessely S, Murray R. 2007. Physical illness and lifestyle risk factors in people with their first presentation of psychosis. Soc Psychiatry Psychiatr Epidemiol 42:117–124.
   PubMedGoogle Scholar
• Shonkoff JP, Levitt P. 2010. Neuroscience and the future of early childhood policy: moving from why to what and how. Neuron 67:689–691.
   PubMed Web of Science ®Google Scholar
• Shonkoff JP, Boyce WT, McEwen BS. 2009. Neuroscience, molecular biology, and the childhood roots of health disparities: building a new framework for health promotion and disease prevention. J Am Med Assoc 301:2252–2259.
   PubMed Web of Science ®Google Scholar
• Smith GS, Gunning-Dixon FM, Lotrich FE, Taylor WD, Evans JD. 2007. Translational research in late-life mood disorders: implications for future intervention and prevention research. Neuropsychopharmacology 32:1857–1875.
   PubMedGoogle Scholar
• Sotiropoulos I, Cerqueira JJ, Catania C, Takashima A, Sousa N, Almeida OF. 2008. Stress and glucocorticoid footprints in the brain-the path from depression to Alzheimer's disease. Neurosci Biobehav Rev 32:1161–1173.
   PubMed Web of Science ®Google Scholar
• Susser M. 1998. Does risk factor epidemiology put epidemiology at risk? Peering into the future. J Epidemiol Community Health 52:608–611.
   PubMed Web of Science ®Google Scholar
• Tandon R, Keshavan MS, Nasrallah HA. 2008. Schizophrenia, “Just the Facts”: what we know in 2008 part 1: overview. Schizophr Res 100:4–19.
   PubMed Web of Science ®Google Scholar
• Taylor SE, Way BM, Welch WT, Hilmert CJ, Lehman BJ, Eisenberger NI. 2006. Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology. Biol Psychiatry 60:671–676.
   PubMed Web of Science ®Google Scholar
• Thapar A, Harold G, Rice F, Langley K, O'Donovan M. 2007. The contribution of gene-environment interaction to psychopathology. Dev Psychopathol 19:989–1004.
   PubMed Web of Science ®Google Scholar
• van Os J, Rutten BP, Poulton R. 2008. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull 34:1066–1082.
   PubMed Web of Science ®Google Scholar
• Van Winkel R, Esquivel G, Kenis G, Wichers M, Collip D, Peerbooms O, . 2010. Review: Genome-wide findings in schizophrenia and the role of gene-environment interplay. CNS Neurosci Ther 16:e185–192.
   PubMed Web of Science ®Google Scholar
• Vita A, De Peri L, Silenzi C, Dieci M. 2006. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res 82:75–88.
   PubMed Web of Science ®Google Scholar
• Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, . 2009. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry 66:617–626.
   PubMed Web of Science ®Google Scholar
• Ward KE, Friedman L, Wise A, Schulz SC. 1996. Meta–analysis of brain and cranial size in schizophrenia. Schizophr Res 22:197–213.
   PubMed Web of Science ®Google Scholar
• WHO. 2011. Global burden of disease. WHO Health Statistics and Health Information Systems. Geneva, WHO.
   Google Scholar
• Wilhelm K, Mitchell PB, Niven H, Finch A, Wedgwood L, Scimone A, . 2006. Life events, first depression onset and the serotonin transporter gene. Br J Psychiatry 188:210–215.
   PubMed Web of Science ®Google Scholar
• Wuwongse S, Chang RC, Law AC. 2010. The putative neurodegenerative links between depression and Alzheimer's disease. Prog Neurobiol 91:362–375.
   PubMed Web of Science ®Google Scholar